Zobrazeno 1 - 10
of 177
pro vyhledávání: '"E, Bayever"'
Publikováno v:
Bone Marrow Transplantation. 33:1253-1256
We report here a monosomy 7 transformation of donor cells following matched-unrelated, same sex, allogeneic bone marrow transplantation in a patient with severe congenital aplastic anemia. A PCR technique was employed to amplify microsatellite marker
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ede4711c782a554d0f7cad31050e43e7
https://doi.org/10.1038/sj.bmt.1704450
https://doi.org/10.1038/sj.bmt.1704450
Autor:
Anne Kessinger, Shantaram M. Joshi, John D. Jackson, E. Bayever, Jene L. Pierson, J. Graham Sharp, Stefano R. Tarantolo, James O. Armitage, Phyllis I. Warkentin, B. O'Kane-Murphy, Patrick L. Iversen, Michael R. Bishop
Publikováno v:
Journal of Hematotherapy. 6:441-446
Effective ex vivo purging techniques can decrease the likelihood of infusing bone marrow contaminated with leukemic cells during autologous transplantation. In preliminary studies, OL(1)p5...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0afd076722cbc95c2271f087363a857b
https://doi.org/10.1089/scd.1.1997.6.441
https://doi.org/10.1089/scd.1.1997.6.441
Autor:
Bruce Geoffrey Gordon, Peter F. Coccia, S. E. Strandjord, Minnie Abromowitch, James Harper, E. Bayever, Phyllis I. Warkentin
Publikováno v:
Bone Marrow Transplantation. 20:5-10
High-dose therapy and allogeneic matched sibling bone marrow transplantation (BMT) is considered to be the treatment of choice for children with relapsed acute lymphoblastic leukemia (ALL), or for children with acute myeloid leukemia (AML) in first r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::824e53108e583de0b8f2bded3fbb4462
https://doi.org/10.1038/sj.bmt.1700827
https://doi.org/10.1038/sj.bmt.1700827
Autor:
John G Sharp, Mark A. Arneson, Patrick L. Iversen, Raymond W. Ruddon, Anne Kessinger, Bryan L. Copple, E. Bayever, J Spinolo, James O. Armitage, Michael R. Bishop, Timothy C. Greiner, Gerald Zon
Publikováno v:
Journal of Clinical Oncology. 14:1320-1326
PURPOSE The phosphoprotein p53 is involved in transcriptional regulation and is detected in hematologic malignancies. In vitro incubation of acute myelogenous leukemia with OL(1)p53, a 20-mer phosphorothioate oligonucleotide complementary to p53 mRNA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44ee3627a3d71ba2103d28e2839d1a5f
https://doi.org/10.1200/jco.1996.14.4.1320
https://doi.org/10.1200/jco.1996.14.4.1320
Autor:
E. Bayever, Patrick L. Iversen
Publikováno v:
Hematological Oncology. 12:9-14
The use of synthetic oligonucleotides directed towards specific genes in the therapy of leukemias has evolved rapidly over the past 5 years to early clinical trials. Undoubtedly, use of these compounds for systemic therapy and bone marrow 'purging' w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd50208ee10fc89080b77950fb51b4c2
https://doi.org/10.1002/hon.2900120103
https://doi.org/10.1002/hon.2900120103
Publikováno v:
Methods in molecular medicine. 1
Current therapy for acute myelogenous leukemia (AML) includes induction with Ara-C and an anthracycline, such as daunorubicin, idarubicin, or mitoxantrone. Unfortunately, most patients relapse from initial remission. Nearly one-fifth of early relapse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::59a67cd6abd8c11238f257dbd657fad5
https://pubmed.ncbi.nlm.nih.gov/21359724
https://pubmed.ncbi.nlm.nih.gov/21359724
Autor:
K. Conard, Naynesh Kamani, D. A. Wenger, J. Radcliffe, Marc Yudkoff, Michael J. Palmieri, Charles S. August, E. Bayever, P. Ferreira, G. A. Machin
Publikováno v:
Journal of Inherited Metabolic Disease. 15:919-928
Bone marrow transplantation has been undertaken with encouraging results as therapy for a wide variety of lysosomal storage diseases. We report a case of Niemann-Pick disease Type IA in which, despite the presence of only mild hypotonia with depresse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e47c706c014b55fd02c2f22f27bf1ae4
https://doi.org/10.1007/bf01800234
https://doi.org/10.1007/bf01800234
Autor:
Marta A. Crispens, Patricia S. Braly, Maurie Markman, A. Lisyanskaya, D. Doering, B. Michiels, D.S. McMeekin, E. Bayever, Amit M. Oza
Publikováno v:
Gynecologic oncology. 114(2)
Objective To assess the efficacy and safety of single-agent trabectedin in women with persistent or recurrent endometrial cancer. Methods In this open-label, phase II multicenter trial, women with persistent or recurrent endometrial carcinoma were ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82fd4c82e9ac68ab76e197d45e781e3e
https://pubmed.ncbi.nlm.nih.gov/19476988
https://pubmed.ncbi.nlm.nih.gov/19476988
Autor:
M. von Mehren, Jonathan D. Cheng, E. Temmer, Z. Yuan, F. G. Renshaw, P. Zannikos, E. Bayever, Roger B. Cohen, Russell J. Schilder, T. M. Cardoso
To determine the maximum tolerated dose (MTD), safety, potential pharmacokinetic (PK) interactions, and effect on liver histology of trabectedin in combination with pegylated liposomal doxorubicin (PLD) for advanced malignancies.Entry criteria for th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d812f4037f378e4b2513d45abb0932d4
https://europepmc.org/articles/PMC2598415/
https://europepmc.org/articles/PMC2598415/
Autor:
Antonio Cubillo, Joon Oh Park, Mark Wong, Javier Gallego, Bruce Belanger, Ik-Joo Chung, Bohuslav Melichar, Jen-Shi Chen, István Láng, Wen Wee Ma, Jung Sub Kim, B. S. Adiwijaya, E. Bayever, Tibor Csoszi, M. Smakal, M.W. Wenczl, Jun Suk Kim, K.M. Rau
Publikováno v:
European Journal of Cancer. 51:S458
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9b63815b04fc766c3e7d58058e40b98c
https://doi.org/10.1016/s0959-8049(16)31281-3
https://doi.org/10.1016/s0959-8049(16)31281-3